Illumina Inc
ILMN
Key stats
- Open
- 204.41
- Day high
- 211.75
- Day low
- 197.81
- Previous close
- 212.93
- Volume
- 1.73M
- VWAP
- 208.48
- 52-week high
- 309.35
- 52-week low
- 112.65
- Market cap
- 32.20B
- Shares out
- 151.20M
- Employees
- 8,650
- Listed
- 2000
About Illumina Inc
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
LABORATORY ANALYTICAL INSTRUMENTS · SAN DIEGO, CA · illumina.com
Options · expiring Nov 20
Nov 12, 4:00 PM ET- Call open interest
- 1.1K
- Put open interest
- 3.4K
- Put/call
- 3.21
- At-the-money IV
- 52.1%
| Contract | Last | Traded | Volume | Open int. | IV |
|---|---|---|---|---|---|
| 210 call | 7.70 | Nov 12, 3:49 PM | 679 | 43 | 52.1% |
| 210 put | 7.11 | Nov 12, 3:42 PM | 53 | 145 | 68.9% |
| 240 put | 30.80 | Nov 12, 3:21 PM | 29 | 339 | 86.7% |
| 200 call | 14.40 | Nov 12, 3:38 PM | 26 | 42 | 42.7% |
| 230 call | 1.50 | Nov 12, 3:53 PM | 20 | 238 | 53.3% |
| 250 put | 40.33 | Nov 12, 2:26 PM | 18 | 264 | 107.4% |
Quarterly results
Massive · Oct 30, 2026| Q3 2026 to Sep 27, 2026 | Q2 2026 to Jun 28, 2026 | Q1 2026 to Mar 29, 2026 | Q4 2025 to Dec 28, 2025 | |
|---|---|---|---|---|
| Revenue | $1.13B | $1.16B | $1.09B | $1.16B |
| Gross profit | $830.00M | $770.00M | $721.00M | $759.00M |
| Operating income | $305.00M | $245.00M | $209.00M | $201.00M |
| Net income | $220.00M | $207.00M | $134.00M | $334.00M |
| Diluted EPS | 1.43 | 1.35 | 0.87 | 2.17 |
| Operating cash flow | $419.00M | $201.00M | $289.00M | $321.00M |
| Assets | $6.81B | $6.65B | $6.56B | $6.64B |
| Liabilities | $3.67B | $3.81B | $3.88B | $3.92B |
| Equity | $3.15B | $2.84B | $2.68B | $2.72B |
Technicals
Massive · Nov 12, 2026- 50-day average249.32
- 200-day average179.23
- RSI (14 days)35.8
Short interest
Massive · Oct 30, 2026- Oct 30, 20268.02M shares · 3.7 days to cover
- Oct 15, 20267.89M shares · 2.9 days to cover
- Sep 30, 20269.47M shares · 1.6 days to cover
- Sep 15, 202610.59M shares · 5.6 days to cover
Splits
Massive · Sep 23, 2008- Sep 23, 20082-for-1
Related companies
MassiveNews coverage
No stories about Illumina Inc right now.